Alembic Pharmaceuticals Limited has informed the Exchange about General Updates: Updated Contact Details of Key Managerial Personnel / Senior Officials pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has filed updated contact details of its Key Managerial Personnel and Senior Officials with BSE and NSE, as required under SEBI Listing Regulations. The update was approved by the Board of Directors at a meeting held on 5th August 2025. Contact details cover the Chairman & CEO, both Managing Directors, Executive Director, CFO, Company Secretary, Head of Corporate Finance & Accounts, and Sr. VP - Finance. The company has its registered office in Vadodara, with a Mumbai-based contact number provided for the Sr. VP - Finance role.
This is a routine regulatory compliance update with no material impact on the company's business, financials, or stock price. Shareholders and investors are unlikely to see any meaningful change from this filing.